Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q2 2024 Earnings Call Transcript August 13, 2024
Mineralys Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.83 EPS, expectations were $-0.73.
Operator: Welcome to the Mineralys Therapeutics Second Quarter 2024 Conference Call. At this time all lines are in a listen-only mode. A question-and-answer session will follow the presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my...
